No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 0741238X AND DT 2014 AND VI 31 AND IP 11
Results: 6
1
2
Clinical Usefulness of Diquafosol for Real-World Dry Eye Patients: A Prospective, Open-Label, Non-Interventional, Observational Study.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1169, doi. 10.1007/s12325-014-0162-4
- By:
- Publication type:
- Article
3
Liraglutide for the Treatment of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Placebo-Controlled Trials.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1182, doi. 10.1007/s12325-014-0164-2
- By:
- Publication type:
- Article
4
Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1119, doi. 10.1007/s12325-014-0166-0
- By:
- Publication type:
- Article
5
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1134, doi. 10.1007/s12325-014-0167-z
- By:
- Publication type:
- Article
6
Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1155, doi. 10.1007/s12325-014-0161-5
- By:
- Publication type:
- Article